0001562180-23-002144.txt : 20230302 0001562180-23-002144.hdr.sgml : 20230302 20230302160633 ACCESSION NUMBER: 0001562180-23-002144 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230301 FILED AS OF DATE: 20230302 DATE AS OF CHANGE: 20230302 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Lim Bryant David CENTRAL INDEX KEY: 0001752888 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39527 FILM NUMBER: 23698890 MAIL ADDRESS: STREET 1: C/O IDERA PHARMACEUTICALS, INC. STREET 2: 505 EAGLEVIEW BLVD., SUITE 212 CITY: EXTON STATE: PA ZIP: 19341 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Prelude Therapeutics Inc CENTRAL INDEX KEY: 0001678660 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 811384762 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 200 POWDER MILL ROAD CITY: WILMINGTON STATE: DE ZIP: 19803 BUSINESS PHONE: (302) 547-3768 MAIL ADDRESS: STREET 1: 200 POWDER MILL ROAD CITY: WILMINGTON STATE: DE ZIP: 19803 FORMER COMPANY: FORMER CONFORMED NAME: Prelude Therapeutics Inc. DATE OF NAME CHANGE: 20160630 4 1 primarydocument.xml PRIMARY DOCUMENT X0306 4 2023-03-01 false 0001678660 Prelude Therapeutics Inc PRLD 0001752888 Lim Bryant David C/O PRELUDE THERAPEUTICS INCORPORATED 200 POWDER MILL ROAD WILMINGTON DE 19803 false true false false Chief Legal Officer, Corp Sec. Employee Stock Option (Right to Buy) 5.93 2023-03-01 4 A false 250000.00 0.00 A 2033-02-28 Common Stock 250000.00 250000.00 D The stock option vests as to 25% of the total shares on March 1, 2024, and thereafter vests as to 1/48 of the total shares monthly until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date. /s/ Bryant D. Lim 2023-03-02